Perrigo Formula Business Sale

✓ Medically reviewed | Published: | Evidence level: 1A
Perrigo has agreed to sell its infant formula business to MeridianMade for up to $175 million, according to Reuters. A change in ownership does not itself establish a change in formula safety or nutrition; families should follow product labels and consult a health professional about feeding concerns.
📅 Published:
✓ Reviewed by iMedic Medical Editorial Team
📄 Pediatric Health

Quick Facts

Reported deal value
Up to $175 million
Buyer
MeridianMade
Product category
Infant formula

What is happening to Perrigo’s infant formula business?

Quick answer: Perrigo plans to sell its infant formula business to MeridianMade in a deal Reuters reported could be worth up to $175 million.

The reported transaction concerns ownership of a formula business, rather than a newly announced change to infant-feeding guidance. Reuters reported that Perrigo agreed to sell the business to MeridianMade for up to $175 million. The report does not, by itself, establish whether particular products, manufacturing sites, or timelines will change.

For parents and caregivers, a company sale is not evidence that a formula is unsafe or that an infant’s current feeding plan should change. Families can check the product name and preparation instructions on the packaging and consult their child’s health professional if they have questions about nutrition, tolerance, or an appropriate alternative.

Could a change in ownership affect formula safety or availability?

Quick answer: Ownership changes can affect how a business is operated, but the sale announcement alone does not show that product safety or availability has changed.

In the United States, infant formula is regulated by the Food and Drug Administration. The FDA sets requirements that include nutrient specifications and manufacturing controls, and it oversees infant formula safety. A change in who owns a business does not remove those regulatory responsibilities.

Availability can depend on production, distribution, and retail supply. Caregivers who cannot find a needed product should ask their pediatrician or another qualified health professional for help choosing a suitable option. Do not dilute formula or use homemade substitutes; follow the package directions for preparation and storage.

What should caregivers do while the sale proceeds?

Quick answer: Caregivers should use formula according to its label and seek individualized advice before changing an infant’s feeding plan.

For routine feeding, use the exact water-to-powder or concentrate ratio stated on the package, prepare and store formula as directed, and discard leftovers according to the label. These steps help reduce avoidable feeding and food-safety risks. If an infant has a medical condition or uses a specialized formula, contact the clinician who manages that care before making a substitution.

Watch for announcements from the manufacturer, retailers, and the FDA if you need product-specific information, such as a recall or a labeling change. If a baby is not feeding well, has signs of dehydration, or develops concerning symptoms, contact a health professional promptly.

Frequently Asked Questions

The reported sale announcement does not itself indicate a recall. For current product-specific recall information, check FDA notices and the product’s identifying details.

The sale alone is not a reason to change an infant’s feeding plan. Ask your child’s health professional before switching, particularly if the infant uses a specialized formula.

Follow the preparation, storage, and feeding instructions on the product label. The FDA also provides consumer information about infant formula.

References

  1. Reuters. “Perrigo to sell infant formula business to MeridianMade for up to $175 million.” October 2026.
  2. U.S. Food and Drug Administration. “Infant Formula.”